These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Methionine positron emission tomography for differentiation of recurrent brain tumor and radiation necrosis after stereotactic radiosurgery--in malignant glioma. Tsuyuguchi N; Takami T; Sunada I; Iwai Y; Yamanaka K; Tanaka K; Nishikawa M; Ohata K; Torii K; Morino M; Nishio A; Hara M Ann Nucl Med; 2004 Jun; 18(4):291-6. PubMed ID: 15359921 [TBL] [Abstract][Full Text] [Related]
4. Optimization of scan initiation timing after Nakajima R; Abe K; Momose M; Fukushima K; Matsuo Y; Kimura K; Kondo C; Sakai S Ann Nucl Med; 2017 Feb; 31(2):190-197. PubMed ID: 27885545 [TBL] [Abstract][Full Text] [Related]
5. [Combined use of positron emission tomography with (18)F-fluorodeoxyglucose and (11)C-methionine for preoperative evaluation of gliomas]. Yamaguchi S; Terasaka S; Kobayashi H; Narita T; Hirata K; Shiga S; Usui R; Tanaka S; Kubota K; Murata J; Asaoka K No Shinkei Geka; 2010 Jul; 38(7):621-8. PubMed ID: 20628188 [TBL] [Abstract][Full Text] [Related]
6. Optimization of semi-quantification in metabolic PET studies with 18F-fluorodeoxyglucose and 11C-methionine in the determination of malignancy of gliomas. Borbély K; Nyáry I; Tóth M; Ericson K; Gulyás B J Neurol Sci; 2006 Jul; 246(1-2):85-94. PubMed ID: 16603193 [TBL] [Abstract][Full Text] [Related]
7. 18F-fluoro-L-thymidine and 11C-methylmethionine as markers of increased transport and proliferation in brain tumors. Jacobs AH; Thomas A; Kracht LW; Li H; Dittmar C; Garlip G; Galldiks N; Klein JC; Sobesky J; Hilker R; Vollmar S; Herholz K; Wienhard K; Heiss WD J Nucl Med; 2005 Dec; 46(12):1948-58. PubMed ID: 16330557 [TBL] [Abstract][Full Text] [Related]
8. Methionine positron emission tomography of recurrent metastatic brain tumor and radiation necrosis after stereotactic radiosurgery: is a differential diagnosis possible? Tsuyuguchi N; Sunada I; Iwai Y; Yamanaka K; Tanaka K; Takami T; Otsuka Y; Sakamoto S; Ohata K; Goto T; Hara M J Neurosurg; 2003 May; 98(5):1056-64. PubMed ID: 12744366 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of early response to radiotherapy in head and neck cancer measured with [11C]methionine-positron emission tomography. Nuutinen J; Jyrkkiö S; Lehikoinen P; Lindholm P; Minn H Radiother Oncol; 1999 Sep; 52(3):225-32. PubMed ID: 10580868 [TBL] [Abstract][Full Text] [Related]
10. Diagnostic accuracy of 11C-methionine PET for differentiation of recurrent brain tumors from radiation necrosis after radiotherapy. Terakawa Y; Tsuyuguchi N; Iwai Y; Yamanaka K; Higashiyama S; Takami T; Ohata K J Nucl Med; 2008 May; 49(5):694-9. PubMed ID: 18413375 [TBL] [Abstract][Full Text] [Related]
11. Diagnostic accuracy of He Q; Zhang L; Zhang B; Shi X; Yi C; Zhang X BMC Cancer; 2019 Apr; 19(1):332. PubMed ID: 30961564 [TBL] [Abstract][Full Text] [Related]
12. [11C]methionine PET, histopathology, and survival in primary brain tumors and recurrence. Ceyssens S; Van Laere K; de Groot T; Goffin J; Bormans G; Mortelmans L AJNR Am J Neuroradiol; 2006 Aug; 27(7):1432-7. PubMed ID: 16908552 [TBL] [Abstract][Full Text] [Related]
13. Correlation of amino-acid uptake using methionine PET and histological classifications in various gliomas. Torii K; Tsuyuguchi N; Kawabe J; Sunada I; Hara M; Shiomi S Ann Nucl Med; 2005 Dec; 19(8):677-83. PubMed ID: 16444993 [TBL] [Abstract][Full Text] [Related]
14. Usefulness of 11C-methionine PET in the evaluation of brain lesions that are hypo- or isometabolic on 18F-FDG PET. Chung JK; Kim YK; Kim SK; Lee YJ; Paek S; Yeo JS; Jeong JM; Lee DS; Jung HW; Lee MC Eur J Nucl Med Mol Imaging; 2002 Feb; 29(2):176-82. PubMed ID: 11926379 [TBL] [Abstract][Full Text] [Related]
15. Differentiation of Brain Tumor Recurrence from Post-Radiotherapy Necrosis with 11C-Methionine PET: Visual Assessment versus Quantitative Assessment. Minamimoto R; Saginoya T; Kondo C; Tomura N; Ito K; Matsuo Y; Matsunaga S; Shuto T; Akabane A; Miyata Y; Sakai S; Kubota K PLoS One; 2015; 10(7):e0132515. PubMed ID: 26167681 [TBL] [Abstract][Full Text] [Related]
16. Impact of 11C-methionine positron emission tomography/computed tomography on radiation therapy planning and prognosis in patients with primary brain tumors. Schinkelshoek M; Lopci E; Clerici E; Alongi F; Mancosu P; Rodari M; Navarria P; van der Hiel B; Scorsetti M; Chiti A Tumori; 2014; 100(6):636-44. PubMed ID: 25688497 [TBL] [Abstract][Full Text] [Related]
17. 11C-methionine (MET) and 18F-fluorothymidine (FLT) PET in patients with newly diagnosed glioma. Hatakeyama T; Kawai N; Nishiyama Y; Yamamoto Y; Sasakawa Y; Ichikawa T; Tamiya T Eur J Nucl Med Mol Imaging; 2008 Nov; 35(11):2009-17. PubMed ID: 18542957 [TBL] [Abstract][Full Text] [Related]
18. Metabolic characterization of childhood brain tumors: comparison of 18F-fluorodeoxyglucose and 11C-methionine positron emission tomography. Utriainen M; Metsähonkala L; Salmi TT; Utriainen T; Kalimo H; Pihko H; Mäkipernaa A; Harila-Saari A; Jyrkkiö S; Laine J; Någren K; Minn H Cancer; 2002 Sep; 95(6):1376-86. PubMed ID: 12216107 [TBL] [Abstract][Full Text] [Related]
19. Differential Diagnosis between Low-Grade and High-Grade Astrocytoma Using System A Amino Acid Transport PET Imaging with C-11-MeAIB: A Comparison Study with C-11-Methionine PET Imaging. Nishii R; Higashi T; Kagawa S; Arimoto M; Kishibe Y; Takahashi M; Yamada S; Saiki M; Arakawa Y; Yamauchi H; Okuyama C; Hojo M; Munemitsu T; Sawada M; Kobayashi M; Kawai K; Nagamachi S; Hirai T; Miyamoto S Contrast Media Mol Imaging; 2018; 2018():1292746. PubMed ID: 30026674 [TBL] [Abstract][Full Text] [Related]
20. Methionine-PET to differentiate between brain lesions appearing similar on conventional CT/MRI scans. Ohmura K; Ikegame Y; Yano H; Shinoda J; Iwama T J Neuroimaging; 2023; 33(5):837-844. PubMed ID: 37246342 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]